Assessing Personalized Medicines in Australia: A National Framework for Reviewing Codependent Technologies

Background. Since the mapping of the human genome in 2003, the development of biomarker targeted therapy and clinical adoption of “personalized medicine” has accelerated. Models for insurance subsidy of biomarker/test/drug packages (“codependent technologies” or technologies that work better togethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Merlin, Tracy, Farah, Claude, Schubert, Camille, Mitchell, Andrew, Hiller, Janet E., Ryan, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757917/
https://www.ncbi.nlm.nih.gov/pubmed/22895559
http://dx.doi.org/10.1177/0272989X12452341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757917/
https://www.ncbi.nlm.nih.gov/pubmed/22895559
http://dx.doi.org/10.1177/0272989X12452341

Ejemplares similares